Lonza reported CHF2.9B in Operating Expenses for its fiscal semester ending in June of 2025.





Operating Expenses Change Date
Akzo Nobel EUR 2.61B 273M Sep/2026
Alcon AG USD 2.36B 423M Sep/2026
Almirall EUR 531.16M 13.76M Jun/2026
AstraZeneca USD 11.55B 674M Sep/2026
BASF EUR 16.49B 719M Sep/2026
Bayer EUR 9.92B 121M Sep/2026
Beiersdorf EUR 4.19B 32M Jun/2026
Covestro EUR 3.24B 5.46B Dec/2025
Demant DKK 10.79B 1.16B Jun/2026
Fresenius EUR 5.24B 19M Sep/2026
Fresenius Medical Care EUR 4.55B 229.7M Sep/2026
Geberit CHF 581.3M 1.3M Dec/2025
Genmab DKK 748M 77M Jun/2026
Givaudan CHF 3B 107M Dec/2025
GlaxoSmithKline GBP 6.03B 227M Sep/2026
GN Store Nord DKK 1.96B 156M Sep/2026
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Johnson Matthey GBP 7.02B 2M Dec/2026
Merck EUR 4.97B 630M Sep/2026
Novartis USD 9.88B 325M Sep/2026
Philips EUR 4.23B 478M Sep/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sanofi EUR 10.51B 598M Sep/2026
Sika AG CHF 4.8B 78.3M Dec/2025
Smith & Nephew USD 2.59B 71M Jun/2026
Solvay EUR 1.06B 8M Sep/2026
UCB EUR 2.96B 196M Dec/2025